GlaxoSmithKline Biopharmaceuticals is a full-service contract manufacturing partner in the development and manufacture of cGMP biopharmaceutical proteins for clinical trials and commercial use.
We offer a fully integrated supply chain solution from bulk drug substance manufacture to fill/finish production using state of the art FDA and European licensed multi-product facilities. Our featured services include low-cost, rapid start-up and manufacture of mammalian and insect cell-derived proteins at up to 5,000 litre scale as well as microbial cell-derived proteins at up to 10,000 litre scale. We provide the flexibility in facility and equipment design to meet your bulk drug substance manufacturing needs.
We also offer fill finish for sterile liquids and freeze dried drug products. Our services also include complete analytical and regulatory services to speed technical transfer and regulatory approval.
As your contract manufacturing partner of choice, we offer:
GSK Biopharmaceuticals is a key strategic unit within GSK’s Global Manufacturing & Supply network and is committed to contract manufacturing. With a bulk manufacturing in the US, secondary filling in the UK and Italy, and an analytical testing laboratory in the UK, we have the experience, knowledge, resources and corporate backing to satisfy all of your requirements for reliable, cost-effective, and high-quality biopharmaceutical contract manufacturing services.
Our capabilities assure you receive a proven, successful, and world-class manufacturing experience.
"The successful solution to your biopharmaceutical needs"
Download our PDF brochures.